http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 12 Jun 2026 12:16:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+Ceesay+Abraham/26639621.html si-local-file:///var/storage/secattach/20260612/26639621.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+Ceesay+Abraham/26639621.html Fri, 12 Jun 2026 12:16:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+Ceesay+Abraham/26639621.html si-local-file:///var/storage/secattach/20260612/26639621.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+Ceesay+Abraham/26639621.html Fri, 12 Jun 2026 12:16:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+09/26636267.html si-local-file:///var/storage/secattach/20260611/26636267.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+09/26636267.html Thu, 11 Jun 2026 16:33:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+09/26636267.html si-local-file:///var/storage/secattach/20260611/26636267.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+09/26636267.html Thu, 11 Jun 2026 16:33:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+RIKER+LAUREN/26634269.html si-local-file:///var/storage/secattach/20260611/26634269.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+RIKER+LAUREN/26634269.html Thu, 11 Jun 2026 11:28:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+RIKER+LAUREN/26634269.html si-local-file:///var/storage/secattach/20260611/26634269.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+RIKER+LAUREN/26634269.html Thu, 11 Jun 2026 11:28:00 -0400 O.00168667 PCRX http://www.streetinsider.com/Corporate+News/Pacira+BioSciences+stockholders+elect+all+three+director+nominees/26625112.html <p>Pacira BioSciences Inc. (NASDAQ: PCRX) announced that stockholders elected all three of the company's director nominees at its 2026 annual meeting. The elected directors are Christopher Christie, Samit Hirawat and Thomas Wiggans.</p><p>The preliminary results were provided by the company's proxy solicitor, D.F. King & Co. Inc. Final results will be tabulated and certified by an independent inspector of elections and reported in a Form 8-K filing with the Securities and Exchange Commission.</p><p>"On behalf of the board and executive leadership team, I would like to express our appreciation and gratitude to our stockholders for their trust in our team and belief http://www.streetinsider.com/Corporate+News/Pacira+BioSciences+stockholders+elect+all+three+director+nominees/26625112.html Tue, 09 Jun 2026 18:42:40 -0400 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/Press+Releases/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.ca.brisbn" idsrc="xmltag.org" >BRISBANE, Calif.</location></span>, <span class="legendSpanClass"><chron>June 9, 2026</chron></span> /PRNewswire/ -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the "Company" or "Pacira"), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that based on the preliminary results of its 2026 Annual Meeting of Stockholders (the "Annual Meeting") provided by its proxy solicitor, <span value="ACORN:4002833135" idsrc="xmltag.org" >D.F. King &amp; Co., Inc.</span>, all three of Pacira's highly qualified director nominees – <person>Christopher Christie</person>, <person>Samit Hirawat</person>, MD and <person>Thomas Wiggans</person> – were elected to the Board of Directors.</p> <p><person>Frank D. Lee</person>, chief executive officer, said, http://www.streetinsider.com/PRNewswire/Pacira+BioSciences+Announces+Stockholders+Have+Elected+All+Three+of+the+Company%27s+Director+Nominees+at+Annual+Meeting/26624981.html Tue, 09 Jun 2026 17:53:00 -0400 A.10371245 A.25644708 A.40028331 O.00040902 O.00168667 O.08192455 O.51342686 PCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+03++Filed+by%3A+WILLIAMS+KRISTEN/26612434.html si-local-file:///var/storage/secattach/20260605/26612434.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+03++Filed+by%3A+WILLIAMS+KRISTEN/26612434.html Fri, 05 Jun 2026 17:57:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+03++Filed+by%3A+WILLIAMS+KRISTEN/26612434.html si-local-file:///var/storage/secattach/20260605/26612434.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Jun+03++Filed+by%3A+WILLIAMS+KRISTEN/26612434.html Fri, 05 Jun 2026 17:57:00 -0400 O.00168667 PCRX